BNP Paribas Financial Markets Raises Holdings in Maximus, Inc. $MMS

BNP Paribas Financial Markets lifted its holdings in shares of Maximus, Inc. (NYSE:MMS) by 136.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 231,401 shares of the health services provider’s stock after acquiring an additional 133,332 shares during the period. BNP Paribas Financial Markets owned approximately 0.42% of Maximus worth $19,975,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Royal Bank of Canada raised its stake in shares of Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares in the last quarter. Jane Street Group LLC lifted its stake in Maximus by 941.2% during the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after acquiring an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Maximus in the 2nd quarter valued at about $204,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Activity

In related news, Director Jan Madsen sold 742 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, Maximus currently has a consensus rating of “Hold”.

Maximus Trading Down 0.0%

Shares of NYSE MMS opened at $60.49 on Friday. Maximus, Inc. has a 12-month low of $56.92 and a 12-month high of $100.00. The company has a market cap of $3.18 billion, a price-to-earnings ratio of 9.06 and a beta of 0.58. The stock’s 50 day simple moving average is $63.79 and its 200 day simple moving average is $76.61. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.98 by $0.09. The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period last year, the firm earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities research analysts expect that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, May 15th. Maximus’s dividend payout ratio (DPR) is 19.76%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.